PMV Pharmaceuticals

Despite the often dismal mood over the weekend, the Asco conference provided rich pickings for some biotech investors.

Liver and other toxicities threaten to scupper another attempt to reactivate mutated p53, the “guardian of the genome”.

June 06, 2022

May 27, 2022

Unveiled abstracts from Asco lift the stock of several biotechs, which will now be under pressure not to disappoint at the conference next week.

August 12, 2021

April 13, 2017

March 10, 2016

Evaluate